Skip to main content

GOLDMAN SACHS GROUP INC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$855,742
-$825,625 QoQ
Shares Held
150,659
-18.0% QoQ
Ownership
0.479%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 143 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. LENZ ranks #261 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LENZ

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $855,742 150,659
2026-03-31 $1,681,367 183,756
2025-12-31 $4,127,072 257,942
2025-09-30 $1,922,635 41,276
2025-03-31 $589,607 22,933
2024-12-31 $1,437,321 49,786
2024-09-30 $784,701 33,054
2024-06-30 $228,625 13,223
2023-12-31 GRPH 28,538
2023-09-30 GRPH 33,779
2023-06-30 GRPH 34,673
2023-03-31 GRPH 13,179
2022-12-31 GRPH 28,602
2022-09-30 GRPH 251,734
2022-06-30 GRPH 418,081
2022-03-31 GRPH 37,286
2021-12-31 GRPH 19,891
2021-09-30 GRPH 74,109
2021-06-30 GRPH 274,426